LMR Partners’s BiomX PHGE Stock Holding History

LMR Partners’s Portfolio PHGE Stock Details PHGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-153	Closed	-$185K	–	1041
2020 Q4	$185K	Hold	153	–	–	﹤0.01%	427
2020 Q3	$184K	Hold	153	–	–	﹤0.01%	351
2020 Q2	$160K	Buy	+153	New	+$170K	﹤0.01%	495

Other funds holding PHGE

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JJIJ

Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TWMP

Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

LMR Partners's PHGE Position: Q1 2021 in Review

LMR Partners sold out of BiomX (PHGE) in Q1 2021, closing a stake of 153 shares — an estimated $185K sold.

LMR Partners first reported a position in PHGE in Q2 2020 and held it in 3 quarters. The position peaked at $185K in Q4 2020. 13 funds tracked by Wall St. Rank hold PHGE as of Q1 2021.

LMR Partners reported no remaining BiomX position as of Q1 2021 after selling out during the quarter.
LMR Partners sold 153 BiomX shares in Q1 2021, an estimated $185K.
LMR Partners first reported a position in BiomX in Q2 2020 and held it in 3 quarters.
LMR Partners's BiomX position peaked at $185K in Q4 2020.
13 funds tracked by Wall St. Rank held BiomX as of Q1 2021.

Based on LMR Partners's 13F filing for Q1 2021, filed 17 May 2021.